1. Istituto De Angeli S.p.a. (10 from 13 patents)

2. Boehringer Ingelheim International Gmbh (4 from 1,536 patents)

3. Boehringer Ingelheim Pharma Kg (4 from 149 patents)

4. Boehringer Ingelheim Italia S.p.a. (2 from 6 patents)

5. Other (1 from 832,843 patents)

6. Ingelheim Italia S.p.a. (1 from 1 patent)

7. Istituto De Angeli (1 from 1 patent)

8. Instituto De Angeli S.p.a. (1 from 1 patent)

9. Boehringer Ingelheim Pharma Gmbh & Co Kg (194 patents)

10. Sprout Pharmaceuticals, Inc. (15 patents)

1. 8916589 - Bradykinin B1-antagonists

2. 8410100 - Pteridinone derivatives as PI3-kinases inhibitors

3. 7429583 - Betamimetics for the treatment of respiratory complaints

4. 7164018 - Polymers based on N-carbamyl-N'-dimethylsilyl methyl-piperazine traceless linkers for the solid phase synthesis of phenyl based libraries

5. 6740712 - Polymers based on N-carbamyl-N'-dimethylsilyl methyl-piperazine traceless linkers for the solid phase synthesis of phenyl based libraries

6. 6586435 - Benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors

7. 6521623 - N,N'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors

8. 6281218 - Benzimidazolone derivatives having mixed serotonin and dopamine receptors affinity

9. 6255327 - Diphenyl-substituted heterocycles, processes for preparing them and their use as pharmaceutical compositions

10. 6235738 - Diphenyl-substituted heterocycles with 6-membered ring, processes for the preparation thereof and the use thereof as medicaments

11. 6002009 - Di-substituted 1,4-piperidine esters and amides having 5-HT4

12. 5468758 - Crystalline forms of

13. 5164386 - R(-)3-quinuclidinol derivatives

14. 4973592 - 1,3-diazocycloalkenes as muscarinic receptor blocking agents

15. 4699915 - Substituted heterocyclyl-phenylformamidines and salts thereof